These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 36716084)

  • 1. Hodgkin Lymphoma in Children and Adolescents of Northern Greece: 25-Year Results and Long-term Follow-up.
    Kourti M; Papakonstantinou E; Papagianni A; Arsos G; Ioannidou M; Pantoleon A; Antari V; Palabougiouki M; Kouskouras K; Venizelos I; Κoletsa T; Cheva A; Anastasiou A; Totikidis G; Tragiannidis A; Galli-Tsinopoulou A; Hatzipantelis E
    J Pediatr Hematol Oncol; 2023 Aug; 45(6):322-326. PubMed ID: 36716084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome of children with nodular lymphocyte predominant Hodgkin lymphoma - a Children's Cancer and Leukaemia Group report.
    Hall GW; Katzilakis N; Pinkerton CR; Nicolin G; Ashley S; McCarthy K; Daw S; Hewitt M; Wallace WH; Shankar A
    Br J Haematol; 2007 Sep; 138(6):761-8. PubMed ID: 17760808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between radiotherapy vs no radiotherapy based on early response to VAMP chemotherapy and survival among children with favorable-risk Hodgkin lymphoma.
    Metzger ML; Weinstein HJ; Hudson MM; Billett AL; Larsen EC; Friedmann A; Howard SC; Donaldson SS; Krasin MJ; Kun LE; Marcus KJ; Yock TI; Tarbell N; Billups CA; Wu J; Link MP
    JAMA; 2012 Jun; 307(24):2609-16. PubMed ID: 22735430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Children and Adolescent Hodgkin Lymphoma in Argentina: Long-term Results After Combined ABVD and Restricted Radiotherapy.
    Zubizarreta PA; Alfaro E; Guitter M; Sanchez La Rosa C; Galluzzo ML; Millán N; Fiandrino F; Felice MS
    J Pediatr Hematol Oncol; 2017 Nov; 39(8):602-608. PubMed ID: 28902084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathologic features and therapy outcome in childhood Hodgkin's lymphoma: a report from tertiary care center in Saudi Arabia.
    Alkhayat N; Alshahrani M; Elyamany G; Sedick Q; Ibrahim W; Hamzi H; Binhassan A; Othman M; Alshieban S; Aljabry MS; Asiri S; Alzouman M; Alsuhaibani O; Alabbas F; Alsharif O; Elborai Y
    J Egypt Natl Canc Inst; 2021 Aug; 33(1):21. PubMed ID: 34396456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapy results in pediatric Hodgkin lymphoma - does less mean better? Experience from a single children's oncology center.
    Stankiewicz J; Kołtan A; Demidowicz E; Bartoszewicz N; Kołtan S; Czyżewski K; Richert-Przygońska M; Dębski R; Pogorzała M; Tejza B; Cisek J; Księżniakiewicz P; Jatczak-Gaca A; Marjańska A; Salamon M; Dąbrowska A; Urbańczyk A; Grześk E; Jaremek K; Łęcka M; Grochowska O; Styczyński J
    Ann Hematol; 2023 Aug; 102(8):2109-2117. PubMed ID: 37195291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Second malignancies after treatment for laparotomy staged IA-IIIB Hodgkin's disease: long-term analysis of risk factors and outcome.
    Mauch PM; Kalish LA; Marcus KC; Coleman CN; Shulman LN; Krill E; Come S; Silver B; Canellos GP; Tarbell NJ
    Blood; 1996 May; 87(9):3625-32. PubMed ID: 8611686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Application of anti-programmed cell death protein 1 antibody in children with refractory or relapsed Hodgkin lymphoma].
    Li Y; Duan YL; Huang M; Zhang L; Jin YG; Zhang XL; Wang X
    Zhonghua Er Ke Za Zhi; 2022 Jun; 60(6):573-577. PubMed ID: 35658365
    [No Abstract]   [Full Text] [Related]  

  • 9. Optimisation of chemotherapy and radiotherapy for untreated Hodgkin lymphoma patients with respect to second malignant neoplasms, overall and progression-free survival: individual participant data analysis.
    Franklin J; Eichenauer DA; Becker I; Monsef I; Engert A
    Cochrane Database Syst Rev; 2017 Sep; 9(9):CD008814. PubMed ID: 28901021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adolescents and young adults with classical Hodgkin lymphoma in northern Tunisia: insights from an adult single-institutional study.
    Zawati I; Adouni O; Finetti P; Manai M; Manai M; Gamoudi A; Birnbaum D; Bertucci F; Mezlini A
    Cancer Radiother; 2020 Jun; 24(3):206-214. PubMed ID: 32171674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Influence of age on treatment results in children and adolescents with Hodgkin's disease].
    Balwierz W; Moryl-Bujakowska A; Depowska T; Klekawka T; Stanuch H; Matysiak M; Sopyło B; Kołakowska-Mrozowska B; Krenke K; Chybicka A; Raś M; Sońta-Jakimczyk D; Moszant A; Wachowiak J; Kaczmarek-Kanold M; Kowalczyk J; Odój T; Balcerska A; Drozyńska E; Wysocki M; Kołtan A; Krawczuk-Rybak M; Stolarska M
    Przegl Lek; 2004; 61 Suppl 2():40-4. PubMed ID: 15686044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical analysis of 135 newly diagnosed patients with Hodgkin lymphoma].
    Zhou J; Wu X; Dai Y; Liu T; Xu C
    Zhonghua Xue Ye Xue Za Zhi; 2014 Apr; 35(4):304-8. PubMed ID: 24759017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics and Survival Outcomes of Children With Hodgkin Lymphoma Treated Primarily With Chemotherapy.
    Ashraf MS; Naz F; Yakoob MY
    J Pediatr Hematol Oncol; 2019 Aug; 41(6):452-456. PubMed ID: 31033793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnosis and treatment of anaplastic large-cell lymphoma in children and adolescents: a retrospective multicenter survey study].
    ;
    Zhonghua Er Ke Za Zhi; 2017 Mar; 55(3):194-199. PubMed ID: 28273702
    [No Abstract]   [Full Text] [Related]  

  • 15. Obstetric and maternal outcomes in patients diagnosed with Hodgkin lymphoma during pregnancy: a multicentre, retrospective, cohort study.
    Maggen C; Dierickx D; Lugtenburg P; Laenen A; Cardonick E; Shmakov RG; Bellido M; Cabrera-Garcia A; Gziri MM; Halaska MJ; Ottevanger PB; Van Calsteren K; O'Laughlin A; Polushkina E; Van Dam L; Avivi I; Vandenberghe P; Woei-A-Jin FJSH; Amant F;
    Lancet Haematol; 2019 Nov; 6(11):e551-e561. PubMed ID: 31564649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The incidence and treatment of the first relapse in children with Hodgkin's disease].
    Balwierz W; Moryl-Bujakowska A; Bogusławska-Jaworska J; Pisarek J; Raś M; Sońta-Jakimczyk D; Janik-Moszant A; Rokicka-Milewska R; Sopylo B; Kolakowska-Mrozowska B; Kołecki P; Kaczmarek-Kanold M; Kowalczyk J; Odój T; Matysiak M; Newecka-Samól T
    Med Wieku Rozwoj; 2000; 4(1 Suppl 2):73-84. PubMed ID: 12021465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome of relapse in children and adolescents with B-cell non-Hodgkin lymphoma and mature acute leukemia: A report from the French LMB study.
    Rigaud C; Auperin A; Jourdain A; Haouy S; Couec ML; Aladjidi N; Gandemer V; Lambliotte A; Plat G; Landman-Parker J; Michon J; Leblanc T; Patte C; Minard-Colin V
    Pediatr Blood Cancer; 2019 Sep; 66(9):e27873. PubMed ID: 31207026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current approaches to the management of pediatric Hodgkin lymphoma.
    Freed J; Kelly KM
    Paediatr Drugs; 2010 Apr; 12(2):85-98. PubMed ID: 20218745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PET-guided eBEACOPP treatment of advanced-stage Hodgkin lymphoma (HD18): follow-up analysis of an international, open-label, randomised, phase 3 trial.
    Kreissl S; Goergen H; Buehnen I; Kobe C; Moccia A; Greil R; Eichenauer DA; Zijlstra JM; Markova J; Meissner J; Feuring-Buske M; Soekler M; Beck HJ; Willenbacher W; Ludwig WD; Pabst T; Topp MS; Hitz F; Bentz M; Keller UB; Kühnhardt D; Ostermann H; Hertenstein B; Aulitzky W; Maschmeyer G; Vieler T; Eich H; Baues C; Stein H; Fuchs M; Diehl V; Dietlein M; Engert A; Borchmann P;
    Lancet Haematol; 2021 Jun; 8(6):e398-e409. PubMed ID: 34048679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors in pediatric Hodgkin lymphoma: experience from a developing country.
    Ghafoor T
    Leuk Lymphoma; 2020 Feb; 61(2):344-350. PubMed ID: 31535950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.